Onto Innovation Inc. (NYSE:ONTO) Q4 2023 Earnings Call Transcript February 8, 2024 Onto Innovation Inc. beats earnings expectations. Reported EPS is $1.06, expectations were $0.99. ONTO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to the […]
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript February 7, 2024 Vanda Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Jeannie and I will be your conference operator today. At this time, […]
Twin Disc, Incorporated (NASDAQ:TWIN) Q2 2024 Earnings Call Transcript February 7, 2024 Twin Disc, Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. I would like to welcome everyone to the Twin […]
Essex Property Trust, Inc. (NYSE:ESS) Q4 2023 Earnings Call Transcript February 7, 2024 Essex Property Trust, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Essex Property Trust Fourth Quarter 2023 Earnings Conference Call. […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2023 Earnings Call Transcript February 7, 2024 Neurocrine Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to Neurocrine Biosciences’ year-end and fourth quarter results call. At this time, all […]